Zhejiang Jingxin Pharmaceutical Co., Ltd.

Shaoxing Jingxin Pharmaceutical Co., Ltd. is a wholly owned subsidiary of Zhejiang Jingxin Pharmaceutical Co., Ltd. (a listed company in China, integrating the R&D, production and marketing for drug substances, traditional Chinese Medicines, drug products, medical devices, etc., has 3 API plants located in Shangyu, Jiangxi and Shandong, respectively), set up in December, 2004. Shaoxing Jingxin Pharmaceutical Co., Ltd. is a wholly owned subsidiary of Zhejiang Jingxin Pharmaceutical Co., Ltd. (a listed company in China, integrating the R&D, production and marketing for drug substances, traditional Chinese Medicines, drug products, medical devices, etc., has 3 API plants located in Shangyu, Jiangxi and Shandong, respectively), set up in December, 2004. It is a leading manufacturer of fluoroquinolones, CNS, Statins APIs, etc.Shaoxing Jingxin Pharmaceutical Co., Ltd. is located in Shaoxing City, Zhejiang Province. It is a leading manufacturer of fluoroquinolones, CNS, Statins APIs, etc.Shaoxing Jingxin Pharmaceutical Co., Ltd. is located in Shaoxing City, Zhejiang Province. The plant area is about 244,000 m2 including multiple production workshops, dedicated warehouses for drug substances and raw materials, independent education background. The plant area is about 244,000 m2 including multiple production workshops, dedicated warehouses for drug substances and raw materials, independent education background. The products are supported QC labs. The products are supported QC labs. The total employee is about 580, of which more than 45% have college degrees or above for domestic market as well as overseas which include US, Europe, Southeast Asia, the Middle East, Latin America etc. The total employee is about 580, of which more than 45% have college degrees or above for domestic market as well as overseas which include US, Europe, Southeast Asia, the Middle East, Latin America etc. The plant has undergone GMP inspections by US FDA, EDQM, WHO, PMDA, ANVISA,COFEPRIS, MFDS and local authority with positive results, i.e. the GMP certificates or equivalent. The plant has undergone GMP inspections by US FDA, EDQM, WHO, PMDA, ANVISA,COFEPRIS, MFDS and local authority with positive results, i.e. the GMP certificates or equivalent. We are open for: ①Contract Manufacturing of Commercialized product for Global market ②Localization Contract Manufacturing of imported products in China ③Contract Manufacturing of Clinical samples of innovative drugs (including placebo) ④Technology Transfer Service from Lab to GMP site: Trial batch, POB, PVB preparation ⑤Support MAHs for distribution in US 、Europe and Emerging markets ⑥CSO: Contract Sales service for China market ⑦OEM for Global market ⑧Joint-venture ⑨License in/out